Cited by 83Bariatric Surgery and OutcomesVagus Nerve Stimulation ResearchPharmacology and Obesity Treatment

Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial

Open access
Shikora, Scott A., Wolfe, Bruce M., Apovian, Caroline M., Anvari, Mehran, Sarwer, David B., Gibbons, Robert D., Ikramuddin, Sayeed, Miller, Christopher J. +4 more·2015·Journal of Obesity

Abstract

Background/Objectives. Vagal block therapy (vBloc) is effective for moderate to severe obesity at one year.Subjects/Methods. The ReCharge trial is a double-blind, randomized controlled clinical trial of 239 participants with body mass index (BMI) of 40 to 45 kg/m or 35 to 40 kg/m with one or more obesity-related conditions. Interventions were implantation of either vBloc or Sham devices and weight management counseling. Mixed models assessed percent excess weight loss (%EWL) and total weight loss (%TWL) in intent-to-treat analyses. At 18 months, 142 (88%) vBloc and 64 (83%) Sham patients remained enrolled in the study.Results. 18-month weight loss was 23% EWL (8.8% TWL) for vBloc and 10% EWL (3.8% TWL) for Sham (P<0.0001). vBloc patients largely maintained 12-month weight loss of 26% EWL (9.7% TWL). Sham regained over 40% of the 17% EWL (6.4% TWL) by 18 months. Most weight regain preceded unblinding. Common adverse events of vBloc through 18 months were heartburn/dyspepsia and abdominal pain; 98% of events were reported as mild or moderate and 79% had resolved.Conclusions. Weight loss with vBloc was sustained through 18 months, while Sham regained weight between 12 and 18 months. vBloc is effective with a low rate of serious complications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2015/365604

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Shikora, S. A., Wolfe, B. M., Apovian, C. M., Anvari, M., Sarwer, D. B., Gibbons, R. D., Ikramuddin, S., Miller, C. J., Knudson, M. B., Tweden, K. S., Sarr, M. G., & Billington, C. J.
Affiliations
  • Brigham and Women's Hospital (US)
  • Oregon Health & Science University (US)
  • Boston University (US)
  • McMaster University (CA)
  • Hospital of the University of Pennsylvania (US)
  • University of Chicago (US)
  • University of Minnesota (US)
  • 3D Communications LLC, 8386 Six Forks Road, Raleigh, NC 27615, USA
  • ReShape Lifesciences (United States) (US)
  • Mayo Clinic (US)
Corresponding author
Tweden, Katherine S.
Venue
Journal of Obesity
Published
2015
Volume
2015
Pages
1-8
ISSN
  • 2090-0708 (ISSN-L)
  • 2090-0716
OpenAlex
W1541214928
Cited by
83
References
11
Citations by year
2026: 1 · 2025: 9 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 6 · 2020: 12 · 2019: 9 · 2018: 13 · 2017: 6 · 2016: 12 · 2015: 3
FWCI
11.42
Type
journal article
Language
en
Open access
Locations
  • Journal of Obesity (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • TUScholarShare (Temple University) (submittedVersion, cc-by)
Funders
  • Oregon Health and Science University
  • Tufts Medical Center
  • University of Minnesota
  • University of Connecticut
  • Virginia Commonwealth University
  • Universidad Nacional Autónoma de México
  • School of Medicine, Stanford University
  • University of Colorado Denver
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
  • Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
Keywords
vagus nerve block, obesity, weight loss, weight regain, sham device, excess weight loss, weight management counseling, obesity-related comorbidities, adverse events
MeSH terms
Double-Blind Method, Dyspepsia, Electrodes, Female, Follow-Up Studies, Heartburn, Humans, Male, Middle Aged, Nerve Block, Obesity, Morbid, United States, Vagus Nerve, Weight Loss, Abdominal Pain, Body Mass Index, Treatment Outcome, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review